Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN13801649) titled 'Trial of Randomised Approaches for National Screening FOR Men (TRANSFORM)' on Oct. 21.
Study Type: Interventional
Study Design:
Randomized controlled study (Screening)
Primary Sponsor: Imperial College London
Condition:
Prostate cancer
Cancer
Intervention:
In this multi-arm multi-stage randomised platform trial, eligible men will be invited via their GP practice for a community-based screening intervention. The trial will involve two stages. In Stage 1 (pilot), two pre-consent randomisation designs will be evaluated. In Design 1, participants will be approached to express interest in joining the TRANSFORM Re...